Arm Symptoms and Overall Survival in Brazilian Patients with Advanced Breast Cancer

被引:0
|
作者
Bergmann, Anke [1 ,2 ]
Bourrus, Nathalia Santos [1 ,2 ]
de Carvalho, Cristiane Monteiro [2 ]
Dias, Ricardo de Almeida [1 ,2 ]
Nogueira Fabro, Erica Alves [2 ]
Sales, Nuria Silva [2 ]
de Aguiar, Suzana Sales [2 ]
机构
[1] Ctr Univ Augusto Motta, Bonsucesso, BR, Brazil
[2] Inst Nacl Canc, Sao Paulo, Brazil
关键词
Breast neoplasms; neoadjuvant therapy; arm symptoms; overall survival; advanced cancer; NEOADJUVANT;
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Introduction: Advanced breast cancer is a very frequent serious public health problem. Objective: This study aimed to analyze the prevalence of arm symptoms and overall survival in affected patients. Methodology: A retrospective cohort study was accomplished in 196 women presenting with advanced breast cancer. A descriptive analysis was carried out by and overall survival probabilities were calculated according to Kaplan-Meier method and Cox regression. Results: Thes included 196 woman had a medium age of 55.9 years, the majority being obese (71.3%) and having a IIIB clinical staging (52.3%). The most prevalent arm symptoms were pain (54.6%), paresthesia in upper limb (8.5%), lymphedema (> 200 ml) (6.6%), shoulder restriction (4.7%) and axillary web syndrome (0.6%). The median follow-up was 18.7 months (SD 7,33), 4.0% of the patients had metastasis and 31.6% were dead. The mean free disease survival was 20.4 months (95% CI 18.4-22.4), and the mean survival time was 26.3 months (95% CI 24.7-28.0). After adjusted the association with arm symptom and overall survival for clinical stage and presence of distant metastasis, the shoulder restriction was a predict variable, were represents the risk 2.59 for worse survival in compared with woman with no shoulder restriction (CI 95% 1.06-5.98). Conclusion: The population studied at this study presented high prevalence of complications earlier than neo adjuvant treatment. After controlling for effects of tumor variables, the shoulder restriction was statistically associated with poor overall survival after 2 years.
引用
收藏
页码:2939 / 2942
页数:4
相关论文
共 50 条
  • [1] Overall Survival with Palbociclib and Fulvestrant in Advanced Breast Cancer
    Turner, N. C.
    Slamon, D. J.
    Ro, J.
    Bondarenko, I
    Im, S-A
    Masuda, N.
    Colleoni, M.
    DeMichele, A.
    Loi, S.
    Verma, S.
    Iwata, H.
    Harbeck, N.
    Loibl, S.
    Andre, F.
    Puyana Theall, K.
    Huang, X.
    Giorgetti, C.
    Huang Bartlett, C.
    Cristofanilli, M.
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2018, 379 (20): : 1926 - 1936
  • [2] Chemotherapy Dose Intensity and Overall Survival Among Patients With Advanced Breast or Ovarian Cancer
    Denduluri, Neelima
    Lyman, Gary H.
    Wang, Yunfei
    Morrow, Phuong Khanh
    Barron, Richard
    Patt, Debra
    Bhowmik, Debajyoti
    Li, Xiaoyan
    Bhor, Menaka
    Fox, Patricia
    Dhanda, Rahul
    Saravanan, Shanmugapriya
    Jiao, Xiaolong
    Garcia, Jacob
    Crawford, Jeffrey
    [J]. CLINICAL BREAST CANCER, 2018, 18 (05) : 380 - 386
  • [3] Overall Survival with Ribociclib plus Fulvestrant in Advanced Breast Cancer
    Slamon, Dennis J.
    Neven, Patrick
    Chia, Stephen
    Fasching, Peter A.
    De Laurentiis, Michelino
    Im, Seock-Ah
    Petrakova, Katarina
    Bianchi, Giulia V.
    Esteva, Francisco J.
    Martin, Miguel
    Nusch, Arnd
    Sonke, Gabe S.
    De la Cruz-Merino, Luis
    Beck, J. Thaddeus
    Pivot, Xavier
    Sondhi, Manu
    Wang, Yingbo
    Chakravartty, Arunava
    Rodriguez-Lorenc, Karen
    Taran, Tetiana
    Jerusalem, Guy
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2020, 382 (06): : 514 - 524
  • [4] Overall Survival With Palbociclib Plus Letrozole in Advanced Breast Cancer
    Slamon, Dennis J.
    Dieras, Veronique
    Rugo, Hope S.
    Harbeck, Nadia
    Im, Seock-Ah
    Gelmon, Karen A.
    Lipatov, Oleg N.
    Walshe, Janice M.
    Martin, Miguel
    Chavez-MacGregor, Mariana
    Bananis, Eustratios
    Gauthier, Eric
    Lu, Dongrui R.
    Kim, Sindy
    Finn, Richard S.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (09)
  • [5] Characteristics and overall survival of an advanced breast cancer cohort in Finland
    Ellonen, A.
    Heinolainen, K.
    Saarinen, S.
    Karlsson, A.
    Carlqvist, P.
    Mandelin, J.
    Utriainen, M.
    Vertuani, S.
    Holm, B.
    [J]. ANNALS OF ONCOLOGY, 2020, 31 : S340 - S340
  • [6] Overall Survival with Ribociclib plus Letrozole in Advanced Breast Cancer
    Hortobagyi, Gabriel N.
    Stemmer, Salomon M.
    Burris, Howard A.
    Yap, Yoon-Sim
    Sonke, Gabe S.
    Hart, Lowell
    Campone, Mario
    Petrakova, Katarina
    Winer, Eric P.
    Janni, Wolfgang
    Conte, Pierfranco
    Cameron, David A.
    Andre, Fabrice
    Arteaga, Carlos L.
    Zarate, Juan P.
    Chakravartty, Arunava
    Taran, Tetiana
    Le Gac, Fabienne
    Serra, Paolo
    O'Shaughnessy, Joyce
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2022, 386 (10): : 942 - 950
  • [7] Predicting Overall Survival and Progression-Free Survival Using Tumor Dynamics in Advanced Breast Cancer Patients
    Hyeong-Seok Lim
    Wan Sun
    Kourosh Parivar
    Diane Wang
    [J]. The AAPS Journal, 21
  • [8] Predicting Overall Survival and Progression-Free Survival Using Tumor Dynamics in Advanced Breast Cancer Patients
    Lim, Hyeong-Seok
    Sun, Wan
    Parivar, Kourosh
    Wang, Diane
    [J]. AAPS JOURNAL, 2019, 21 (02):
  • [9] THE EFFECT OF DENDRITIC CELL THERAPY ON THE OVERALL SURVIVAL OF PATIENTS WITH LOCALLY ADVANCED OR METASTATIC BREAST CANCER
    Tiangco, B.
    Batac, J. A. L.
    Tobias, K. K. S.
    Aligui, G.
    [J]. CYTOTHERAPY, 2015, 17 (06) : S24 - S25
  • [10] Impact of Preoperative vs Postoperative Radiotherapy on Overall Survival of Locally Advanced Breast Cancer Patients
    Deng, Yujiao
    Li, Hongtao
    Zheng, Yi
    Zhai, Zhen
    Wang, Meng
    Lin, Shuai
    Li, Yizhen
    Wei, Bajin
    Xu, Peng
    Wu, Ying
    Deng, Xinyue
    Yang, Si
    Lyu, Jun
    Hu, Jingjing
    Dong, Huaying
    Dai, Zhijun
    [J]. FRONTIERS IN ONCOLOGY, 2021, 11